TY - JOUR
T1 - Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma
AU - Windon, Melina J.
AU - D'Souza, Gypsyamber
AU - Waterboer, Tim
AU - Rooper, Lisa
AU - Westra, William H.
AU - Troy, Tanya
AU - Pardoll, Drew
AU - Tan, Marietta
AU - Yavvari, Siddhartha
AU - Kiess, Ana P.
AU - Miles, Brett
AU - Mydlarz, Wojciech K.
AU - Ha, Patrick K.
AU - Bender, Noemi
AU - Eisele, David W.
AU - Fakhry, Carole
N1 - Publisher Copyright:
© 2020 Wiley Periodicals, Inc.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Background: Human papillomavirus (HPV)-positive oropharyngeal cancer (HPV-OPC) is distinct from HPV-unassociated head and neck cancer. However, whether risk factors for HPV-positive oropharyngeal and nonoropharyngeal squamous cell cancer are the same is unclear. Methods: Incident cases of HPV-positive head and neck cell cancer and matched non-cancer controls were enrolled in a multi-institutional, prospective study examining risk factors, biomarkers, and survival. Results: HPV-nonOPC (n = 20) were more likely to be ever smokers than controls (n = 80, OR 3.49, 95%CI 1.11-10.9) and HPV-OPC (n = 185, OR 3.28, 95%CI 1.10-10.2). Compared with HPV-OPC, HPV-nonOPC were less likely to have had over 3 oral sexual partners (OR 0.29, 95%CI 0.06-0.9), more likely to have multimorbidity (OR 3.30, 95%CI 1.04-10.5), and less likely to have antibodies to HPV16 E6 (90% vs 28%, OR 0.05, 95%CI 0.02-0.2). HPV-nonOPC had worse 4-year OS (77% vs 96%, P =.001) and RFS (69% vs 94%, P <.001) than HPV-OPC. Conclusions: HPV-positive nonoropharyngeal are distinct from HPV-positive oropharyngeal cancers.
AB - Background: Human papillomavirus (HPV)-positive oropharyngeal cancer (HPV-OPC) is distinct from HPV-unassociated head and neck cancer. However, whether risk factors for HPV-positive oropharyngeal and nonoropharyngeal squamous cell cancer are the same is unclear. Methods: Incident cases of HPV-positive head and neck cell cancer and matched non-cancer controls were enrolled in a multi-institutional, prospective study examining risk factors, biomarkers, and survival. Results: HPV-nonOPC (n = 20) were more likely to be ever smokers than controls (n = 80, OR 3.49, 95%CI 1.11-10.9) and HPV-OPC (n = 185, OR 3.28, 95%CI 1.10-10.2). Compared with HPV-OPC, HPV-nonOPC were less likely to have had over 3 oral sexual partners (OR 0.29, 95%CI 0.06-0.9), more likely to have multimorbidity (OR 3.30, 95%CI 1.04-10.5), and less likely to have antibodies to HPV16 E6 (90% vs 28%, OR 0.05, 95%CI 0.02-0.2). HPV-nonOPC had worse 4-year OS (77% vs 96%, P =.001) and RFS (69% vs 94%, P <.001) than HPV-OPC. Conclusions: HPV-positive nonoropharyngeal are distinct from HPV-positive oropharyngeal cancers.
KW - HPV
KW - biomarkers
KW - head and neck cancer
KW - oropharyngeal cancer
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85080043273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080043273&partnerID=8YFLogxK
U2 - 10.1002/hed.26116
DO - 10.1002/hed.26116
M3 - Article
C2 - 32101350
AN - SCOPUS:85080043273
SN - 1043-3074
VL - 42
SP - 1954
EP - 1962
JO - Head and Neck
JF - Head and Neck
IS - 8
ER -